U2FP CureCast

Today's conversation features my co-host Jason Stoffer, our new development director, Quinn Brett, and their filmmaker and adventure buddy Robbie Prechtl. Last year, Jason and Quinn completed a rim to rim trip of the Grand Canyon on handcycles(!). They were accompanied by Rob and a team of friends who came along for the adventure and assistance. In case you don’t know, doing a rim to rim journey t...

Every year, U2FP puts on an annual science and advocacy symposium. It's a two day event where we bring together people from the SCI community, researchers, clinicians, industry representatives, and funders in an effort to educate our community about the science of curative therapies. We also hope it provides them with a better understanding of the scientific enterprise. But it’s also a conference...

Today we are speaking with Dimitry Sayenko. Dimitry is an MD, PhD and an associate professor in Neuromodulation and Nuerosurgery at Houston Methodist Hospital, in Houston, Texas. Our conversation starts off with an exploration of Dimitry’s fascinating beginnings, studying muscle atrophy and bone density in the context of aerospace in both Russia and the U.S. We also talk about his current work stu...

Today’s conversation is a highly anticipated one. For years we’ve been hearing about the groundbreaking work of Jerry Silver to render the injury scar permeable to axon growth. That work led to development of the pharmacologic NVG-291 and the associated company NervGen Pharma. The research has finally advanced to a human SCI clinical trial, led by Monica Perez, PT, PhD, who's today's guest. Dr. Pe...

Today we’re talking with Ceren Yarar-Fisher, PhD, PT. Dr. Yarar-Fisher is Vice Chair of Research of Physical Medicine and Rehabilitation in the Dept. of Neuroscience at The Ohio State University. She’s also the director of clinical research at the Belford Center for Spinal Cord Injury. In this episode, we start off exploring the unique origins of Ceren’s interest in science and later spinal cord i...

Our guest today is Meghan Moynihan. Megan is the executive director of the Institute for Functional Restoration, or IFR, a not-for-profit organization based at Case Western Reserve University in Cleveland, Ohio. The IFR seeks to further functional recovery in spinal cord injury by developing commercial strategies to get that research to market. We discuss Megan's background as a researcher and her...

Our conversation today is with David McMillan, an assistant professor at the University of Miami Leonard M. Miller School of Medicine, Department of Neurological Surgery, and Director of Education and Outreach for The Miami Project to Cure Paralysis. Jason and Julie recorded this interview with David onsite at this year's Science and Advocacy Symposium in Minneapolis, where we had a booth set up....

Today’s episode is a bit different. We’re turning the mic towards our own work here at U2FP to let you in on what’s cooking. Jason and Matthew begin by discussing some unique developments with our Team U2FP racers involving extreme heat, adaptive trikes, and a trek along the rim of the Grand Canyon(!). We also discuss U2FP’s upcoming symposium, including how we designed the spinal stim panel, our...

Today we are talking with Yi-Kai Lo and Katie Velez of the SCI research and tech company, Aneuvo. Anuevo has been busy working with investors, the FDA, and multiple research sites to clinically deploy the ExaStim, a novel transcutaneous stimulation device. The goal of their current ASPIRE study is to improve upper limb function. We discuss Dr. Lo’s background in tech and how he was inspired to put...

The topic of today’s conversation is the Vagus nerve. In Latin, Vagus means wandering or straying, which this conversation does a fair bit of due to the interesting subject matter. Our guide on this path is Dr. Patrick Ganzer of the Miami Project to Cure Paralysis. Dr. Ganzer gives us a great overview of the vagus nerve including its possible evolutionary benefits, early explorations and its uniqu...

Today's guest is Dr. Kim Anderson, a friend and a very influential researcher who we have a really great conversation with. We begin with the story of her spinal cord injury along with her early studies and research, and that leads into one of the things she’s known for: her work on patient preference as a result of directly surveying the spinal cord injury community. Finally, we explore how this...

Today, our guest is Louise Phipps Senft. Louise is the mother to a son with an SCI, and founder of Blink of an Eye, a nonprofit organization that is committed to addressing that initial moment when everything changes after a spinal cord injury. A big theme of this conversation is trauma. And one of the things that arises in our dialogue with Louise is how this emotional trauma kind of goes under o...

What you are about to hear is one of the richest conversations we’ve ever had on the show. Our guests today are Gabriel Rodreick (Matthew’s son) and Julie Censullo (CureCast producer) who are here to discuss an audio-art project they created together called “Life Begins in the Stillness” - which we play at the top of the episode. We then dive into their relationship with spinal cord injury, with e...

CureCast co-host Jason Stoffer was injured 5 and ½ years ago. Earlier this year, his friend Lewis Johnson sustained a spinal cord injury. The similarities are uncanny: they were both in the same career field; they both went to the same inpatient hospital; and they both attended the same inpatient rehab facility. For Jason, the big question on the table is this: What has changed in 5 years? What pr...

What if we could take all the neural trash that forms in the spinal cord after an injury, the stuff that hinders connectivity, and turn it into treasure? This is the idea behind cellular reprogramming. Today's podcast guest, Dr. Arshak Alexanian, is a biochemist and the Chief Scientific Officer at the Wisconsin biotech firm, Cell Reprogramming & Therapuetics, LLC. We met Dr. Alexanian not too long...

Today's guest on the podcast is Kym Eisner, the executive director of the Craig H. Neilsen Foundation. This year happens to be the Neilsen Foundation’s 20th anniversary. For those who are unfamiliar with the Foundation, its namesake Craig H. Neilsen, was an entrepreneur who sustained a spinal cord injury in 1985 and formed the foundation in 2002. This was an attempt to catalyze research and suppor...

Have you ever wondered what it feels like to participate in an SCI clinical research trial? How do you find out about these trials? How do you find out about these trials? Does anyone make a recovery? What are some reasons that you might take the leap - or not? On today’s podcast, you’ll get some answers to these questions and many more. Our guests, Mandy Mackenzie and Laura Grabowski, have each p...

Today’s episode is a rebroadcast of our conversation with Grégoire Courtine from two years ago. Dr. Courtine has been pivotal in the successful application of epidural stimulation in humans with SCI, in both his research and device commercialization. In this episode, we talk about Dr. Courtine’s motivation to study spinal cord injury and epidural stimulation in particular. We discuss the translati...

Today our guest is Dan Hellenbrand, a renaissance man of sorts. Dan sustained a cervical injury (C5-6) as a carpenter back in 2003 and ended up going back to school to become a SCI researcher, as well as an advocate for curative therapies. We have an interesting conversation about early physical therapy, the role of belief and competition with yourself and how that aids recovery. We also discuss D...

Today's conversation is a rebroadcast of our interview with Samuel Stupp back in 2022. We thought it was a good time to revisit this conversation, given Dr. Stupp’s most recent publication, which you can learn more about below in the summary review done by U2FP’s science writer, Sam Maddox. More info and research links here: https://u2fp.org/get-educated/curecast/episode-76.html As always, please...

Today’s episode revisits important elements and loose ends of spinal cord stimulation (SCS) that didn’t fit neatly into the arc of our first three conversations on this topic. We’re calling this installment the ‘Junk Drawer’ - not because we consider these loose ends to be junk, but because they represent the multi-directional potential of stimulation’s promise that are on the horizon. This includ...

Today we talk with Bill Murphy, a bioengineer out of the University of Wisconsin Madison. We recently met Dr. Murphy when he came to the Wisconsin Capitol in support of our $3M SCI Research Grant bill back in January. Bill’s team has been working on developing biomaterials to improve the body’s ability to receive and utilize Chondroitinase ABC (ChABC). ChABC is an enzyme that holds lots of promise...

This is the third and final (for now) installment of our 101 tour of spinal stimulation. We're joined again by Sam Maddox, U2FP's Scientific Advisory Board Director and veteran science journalist. Today, we discuss the commercialization of spinal stim, detailing the path that these therapies will need to traverse to arrive at the market. We talk about how labs and businesses are organized and revi...

We’re continuing our conversation around spinal cord stimulation in part 2 of this multi-episode series with Sam Maddox, a long-time SCI science writer and U2FP’s Scientific Advisory Board Director. Today we’re going to focus on what’s happening currently with some spinal stimulation researchers, what clinical outcomes they are targeting, how they are connected to each other and how their approach...

Jason and Matthew talk with U2FP Scientific Advisory Board (SAB) Director and Science Writer, Sam Maddox in the first part of our series on Spinal Stimulation. We’ve been thinking about the need for a discussion on what spinal stimulation is, why it's been studied so extensively, who are the influential scientists and players in the space, the trajectory of where and how it started as an explorati...